-
- Joeky T Senders
- Department of Neurosurgery, University Medical Center, Utrecht, the Netherlands
-
- Omar Arnaout
- Cushing Neurosurgery Outcomes Cen-ter, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
-
- Aditya V Karhade
- Cushing Neurosurgery Outcomes Cen-ter, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
-
- Hormuzdiyar H Dasenbrock
- Cushing Neurosurgery Outcomes Cen-ter, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
-
- William B Gormley
- Cushing Neurosurgery Outcomes Cen-ter, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
-
- Marike L Broekman
- Department of Neurosurgery, University Medical Center, Utrecht, the Netherlands
-
- Timothy R Smith
- Cushing Neurosurgery Outcomes Cen-ter, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
書誌事項
- 公開日
- 2017-09-07
- DOI
-
- 10.1093/neuros/nyx384
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
説明
<jats:title>Abstract</jats:title> <jats:sec> <jats:title>BACKGROUND</jats:title> <jats:p>Machine learning (ML) is a domain of artificial intelligence that allows computer algorithms to learn from experience without being explicitly programmed.</jats:p> </jats:sec> <jats:sec> <jats:title>OBJECTIVE</jats:title> <jats:p>To summarize neurosurgical applications of ML where it has been compared to clinical expertise, here referred to as “natural intelligence.”</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS</jats:title> <jats:p>A systematic search was performed in the PubMed and Embase databases as of August 2016 to review all studies comparing the performance of various ML approaches with that of clinical experts in neurosurgical literature.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>Twenty-three studies were identified that used ML algorithms for diagnosis, presurgical planning, or outcome prediction in neurosurgical patients. Compared to clinical experts, ML models demonstrated a median absolute improvement in accuracy and area under the receiver operating curve of 13% (interquartile range 4-21%) and 0.14 (interquartile range 0.07-0.21), respectively. In 29 (58%) of the 50 outcome measures for which a <jats:italic toggle="yes">P</jats:italic>-value was provided or calculated, ML models outperformed clinical experts (<jats:italic toggle="yes">P</jats:italic> < .05). In 18 of 50 (36%), no difference was seen between ML and expert performance (<jats:italic toggle="yes">P</jats:italic> > .05), while in 3 of 50 (6%) clinical experts outperformed ML models (<jats:italic toggle="yes">P</jats:italic> < .05). All 4 studies that compared clinicians assisted by ML models vs clinicians alone demonstrated a better performance in the first group.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSION</jats:title> <jats:p>We conclude that ML models have the potential to augment the decision-making capacity of clinicians in neurosurgical applications; however, significant hurdles remain associated with creating, validating, and deploying ML models in the clinical setting. Shifting from the preconceptions of a human-vs-machine to a human-and-machine paradigm could be essential to overcome these hurdles.</jats:p> </jats:sec>
収録刊行物
-
- Neurosurgery
-
Neurosurgery 83 (2), 181-192, 2017-09-07
Ovid Technologies (Wolters Kluwer Health)